Is Midostaurin available in China in 2023?

Midostaurin (Midostaurin), also known asRydapt, is an oral multi-target tyrosine kinase inhibitor that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of leukemia. Here is some information about midostaurin.

Currently Midostaurin is not available in China, so patients cannot purchase it domestically. Midostaurin abroad is divided into original drugs and generic drugs. The cheaper original version is the Indian version, which costs more than 10,000 yuan. Others include Turkish and European original drugs, which cost tens of thousands to hundreds of thousands, which are relatively expensive. Generic drugs are mainly Indian generic drugs, which cost about several thousand yuan per box. They are much cheaper than the original drug, and the drug ingredients are basically the same as the original drug.

Midostaurin was originally developed to treat acute myeloid leukemia (AML), a serious blood cancer. Its mechanism of action includes inhibiting multiple kinases, including FLT3, KIT, and PDGFRA etc. FLT3Internal rearrangements or mutations are associated with poor prognosis in AML patients, so midostaurin is particularly important for this subpopulation of patients.

The FDA approved midostaurin in 2017, making it a treatment option for AML patients. The drug is often used in combination with standard chemotherapy to improve patients' survival rates. Its approval also demonstrates the potential for personalized medicine, as patients with specific genetic mutations could benefit from such targeted treatments.

In addition toAML, midostaurin is also used to treat a rare histiocytic hypertrophic disorder—systemic mast cell disease (SMC). SMCusually causes abnormal growth of skin, bones, internal organs and other parts, and midostaurin can help reduce symptoms and improve patients' quality of life.

While midostaurin has shown significant efficacy in certain types of leukemia and histiocytic hypertrophic diseases, it can also cause a range of different side effects, such as nausea, vomiting, diarrhea, rash, etc. Therefore, doctors usually decide whether to use this drug and the dosage based on the patient's specific situation and type of disease.